7-147343905-A-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.1498+43615A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.642 in 152,000 control chromosomes in the GnomAD database, including 32,411 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.64 ( 32411 hom., cov: 32)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.806

Publications

3 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.817 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CNTNAP2NM_014141.6 linkc.1498+43615A>G intron_variant Intron 9 of 23 ENST00000361727.8 NP_054860.1
CNTNAP2XM_017011950.3 linkc.1498+43615A>G intron_variant Intron 9 of 13 XP_016867439.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CNTNAP2ENST00000361727.8 linkc.1498+43615A>G intron_variant Intron 9 of 23 1 NM_014141.6 ENSP00000354778.3

Frequencies

GnomAD3 genomes
AF:
0.642
AC:
97433
AN:
151882
Hom.:
32361
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.824
Gnomad AMI
AF:
0.592
Gnomad AMR
AF:
0.589
Gnomad ASJ
AF:
0.549
Gnomad EAS
AF:
0.417
Gnomad SAS
AF:
0.562
Gnomad FIN
AF:
0.568
Gnomad MID
AF:
0.503
Gnomad NFE
AF:
0.584
Gnomad OTH
AF:
0.571
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.642
AC:
97533
AN:
152000
Hom.:
32411
Cov.:
32
AF XY:
0.637
AC XY:
47341
AN XY:
74278
show subpopulations
African (AFR)
AF:
0.824
AC:
34186
AN:
41478
American (AMR)
AF:
0.589
AC:
8994
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.549
AC:
1904
AN:
3466
East Asian (EAS)
AF:
0.418
AC:
2159
AN:
5162
South Asian (SAS)
AF:
0.562
AC:
2706
AN:
4816
European-Finnish (FIN)
AF:
0.568
AC:
5995
AN:
10560
Middle Eastern (MID)
AF:
0.500
AC:
147
AN:
294
European-Non Finnish (NFE)
AF:
0.584
AC:
39707
AN:
67938
Other (OTH)
AF:
0.567
AC:
1196
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1706
3412
5117
6823
8529
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
780
1560
2340
3120
3900
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.615
Hom.:
5235
Bravo
AF:
0.650
Asia WGS
AF:
0.481
AC:
1674
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
1.1
DANN
Benign
0.57
PhyloP100
-0.81
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs7803992; hg19: chr7-147040997; API